e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future!
Annane D., Umberto Meduri G., Marik P.
Source:
Eur Respir J 2008; 31: 1150-1152
Journal Issue:
June
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Annane D., Umberto Meduri G., Marik P.. Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future!. Eur Respir J 2008; 31: 1150-1152
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Are corticosteroids useful in community-acquired pneumonia?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
Corticosteroids for community-acquired pneumonia: are we still there?
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Cost of treatment failure in community-acquired pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 195s
Year: 2007
Should steroids be used in community-acquired pneumonia? Pro argument
Source: International Congress 2017 – Controversies in community-acquired pneumonia: a pro and con debate
Year: 2017
Mortality in COPD patients with community-acquired pneumonia: who is the third partner?
Source: Eur Respir J 2006; 28: 262-263
Year: 2006
COPD: what is the frequency and impact of community-acquired pneumonia?
Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know?
Year: 2008
Low-dose corticosteroids during severe community-acquired pneumonia: end of the story
Source: Eur Respir J 2015; 45: 305-307
Year: 2015
Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Lower respiratory tract infections: when are antibiotics mandatory?
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146
Year: 2004
What is pneumonia?
Source: Breathe, 17 (3) 210087; 10.1183/20734735.0087-2021
Year: 2021
Clinical failure in community-acquired pneumonia
Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases
Year: 2014
Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Hospitalized community-acquired pneumonia in the elderly: etiology and comorbidities
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Challenges in steroids and anicoagulants in severe COVID-19 pneumonia
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
"Masks" of severe pneumonia (retrospective analysis of letal severe community-acquired pneumonia (sCAP))
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Treatment of severe community-acquired pneumonia: new horizons
Source: International Congress 2014 – Advances in managing acute respiratory failure
Year: 2014
Clinical stability and switch therapy in hospitalised patients with community-acquired pneumonia: are we there yet?
Source: Eur Respir J 2013; 41: 5-6
Year: 2013
Systemic corticosteroid for treating severe community-acquired pneumonia
Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept